In conclusion, through the generation of several mouse models and integrative genomic studies including a human tRCC cohort, we provide insight into molecular mechanisms of ASPSCR1-TFE3–mediated transformation and add to the models available for the research community. This evidence concerns the gene TFE3 and renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.